Cargando…
AB33. Botox: the novel therapy for OAB
Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708434/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s033 |
_version_ | 1782409467684454400 |
---|---|
author | Deng, Donna |
author_facet | Deng, Donna |
author_sort | Deng, Donna |
collection | PubMed |
description | Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action of this drug, the efficacy, and clinical precautions to ensure a safe and successful result for the patient. |
format | Online Article Text |
id | pubmed-4708434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-47084342016-01-26 AB33. Botox: the novel therapy for OAB Deng, Donna Transl Androl Urol Podium Lecture Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action of this drug, the efficacy, and clinical precautions to ensure a safe and successful result for the patient. AME Publishing Company 2014-09 /pmc/articles/PMC4708434/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s033 Text en 2014 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Podium Lecture Deng, Donna AB33. Botox: the novel therapy for OAB |
title | AB33. Botox: the novel therapy for OAB |
title_full | AB33. Botox: the novel therapy for OAB |
title_fullStr | AB33. Botox: the novel therapy for OAB |
title_full_unstemmed | AB33. Botox: the novel therapy for OAB |
title_short | AB33. Botox: the novel therapy for OAB |
title_sort | ab33. botox: the novel therapy for oab |
topic | Podium Lecture |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708434/ http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s033 |
work_keys_str_mv | AT dengdonna ab33botoxthenoveltherapyforoab |